BRIEF-Prospect Park Capital says will not receive milestone payment held onto upon sale of interest in IOI
March 29 Prospect Park Capital Corp
* Says advised by Serenity Pharmaceuticals co will not receive milestone payment which it held onto upon sale of interest in IOI
* Says prospect park's final return on its investment in IOI remains at 8%.
* Will not receive payment in light of Allergan exercising unilateral right to terminate license, transfer, development agreement with Serenity Source text for Eikon: Further company coverage:
Itaú's Setubal sees high growth at Brazil's XP
SAO PAULO, June 24 The price that Itaú Unibanco Holding SA paid for a minority stake in Brazilian independent securities firm XP Investimentos SA embeds "very high growth rates" ahead, co-Chairman Roberto Setubal said on Saturday.
UPDATE 1-Arconic knowingly supplied flammable panels for use in tower -emails
LONDON, June 24 Six emails sent by and to an Arconic Inc sales manager raise questions about why the company supplied combustible cladding to a distributor for use at Grenfell Tower, despite publicly warning such panels were a fire risk for tall buildings.